Logo 6 a1e69dad97a22b9caa5aa6c606f6ea7f9e9b8c4d0352141ae8a7e9bed5512ee3
  • Antibodies
  • Assays/Kits
  • Proteins/Peptides
  • siRNAs/Functional Genomics
  • Biochemicals
  • cDNA Clones
  • Cell/Tissue/Blood Products
  • Genes
  • Images

BMS 299897

Name BMS 299897
Supplier R&D Systems
Catalog 2870
Prices $205.00
Sizes 10 mg
Cas Number 290315-45-6
Chemical Name 2-[(1R)-1-[[(4-Chlorophenyl)sulfonyl](2,5-difluorophenyl)amino]ethyl-5-fluorobenzenebutanoicacid
Formula C24H21ClF3NO4S
Molecular Weight 511.94
Purity >98%
Supplier Page Shop

Product References

Dynamics of {beta}-amyloid reductions in brain, cerebrospinal fluid, and plasma - Dynamics of {beta}-amyloid reductions in brain, cerebrospinal fluid, and plasma

Barten DM, Guss VL, Corsa JA, Loo A, Hansel SB, Zheng M, Munoz B, Srinivasan K, Wang B, Robertson BJ, Polson CT, Wang J, Roberts SB, Hendrick JP, Anderson JJ, Loy JK, Denton R, Verdoorn TA, Smith DW, Felsenstein KM. J Pharmacol Exp Ther. 2005 Feb;312(2):635-43. Epub 2004 Sep 27.

Reductions in beta-amyloid concentrations in vivo by the gamma-secretase - Reductions in beta-amyloid concentrations in vivo by the gamma-secretase

Anderson JJ, Holtz G, Baskin PP, Turner M, Rowe B, Wang B, Kounnas MZ, Lamb BT, Barten D, Felsenstein K, McDonald I, Srinivasan K, Munoz B, Wagner SL. Biochem Pharmacol. 2005 Feb 15;69(4):689-98. Epub 2005 Jan 7.

Ex vivo occupancy of gamma-secretase inhibitors correlates with brain - Ex vivo occupancy of gamma-secretase inhibitors correlates with brain

Goldstein ME, Cao Y, Fiedler T, Toyn J, Iben L, Barten DM, Pierdomenico M, Corsa J, Prasad CV, Olson RE, Li YW, Zaczek R, Albright CF. J Pharmacol Exp Ther. 2007 Oct;323(1):102-8. Epub 2007 Jul 19.



Privacy
Terms
About us
Contact us

Copyright© 2025. All Rights Reserved